RU2190591C1 - 2-methyl-3-phythyl-1,4-naphthoquinone highly labeled with tritium - Google Patents
2-methyl-3-phythyl-1,4-naphthoquinone highly labeled with tritium Download PDFInfo
- Publication number
- RU2190591C1 RU2190591C1 RU2001115959/04A RU2001115959A RU2190591C1 RU 2190591 C1 RU2190591 C1 RU 2190591C1 RU 2001115959/04 A RU2001115959/04 A RU 2001115959/04A RU 2001115959 A RU2001115959 A RU 2001115959A RU 2190591 C1 RU2190591 C1 RU 2190591C1
- Authority
- RU
- Russia
- Prior art keywords
- tritium
- labeled
- naphthoquinone
- methyl
- phythyl
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Изобретение относится к области органической химии и может найти применение в биологии. The invention relates to the field of organic chemistry and may find application in biology.
При изучении физиологически активных соединений требуются их меченые аналоги. When studying physiologically active compounds, their labeled analogues are required.
Известен 2-метил-3-фитил-1,4-нафтохинон формулы I:
Данное соединение, получившее название "филлохинон", является фоточувствительным веществом и находит широкое использование в экспериментах, связанных с исследованием зеленых растений и бактерий K. Brettel et al., FEBS Letters 203, 220 (1986).Known 2-methyl-3-wick-1,4-naphthoquinone of the formula I:
This compound, called "phylloquinone", is a photosensitive substance and is widely used in experiments related to the study of green plants and bacteria K. Brettel et al., FEBS Letters 203, 220 (1986).
Однако меченные тритием аналоги данного известного соединения не описаны. However, tritium-labeled analogues of this known compound are not described.
Техническим результатом, достигаемым настоящим изобретением, является расширение ассортимента меченых аналогов физиологически активных соединений. The technical result achieved by the present invention is to expand the range of labeled analogues of physiologically active compounds.
Указанный технический результат достигается тем, что получен новый высокомеченный тритием 2-метил-3-фитил-1,4-нафтохинон формулы I. The specified technical result is achieved by the fact that a new highly labeled with tritium 2-methyl-3-wick-1,4-naphthoquinone of the formula I is obtained.
Ниже приведены примеры реализации изобретения. The following are examples of the implementation of the invention.
Пример 1. В реакционную ампулу помещали 5 мг филлохинона, нанесенного на 50 мг катализатора Линдлара на основе 5% Pd/BaS04. Затем ампулу вакуумировали до давления 0,1 Па, заполняли газообразным тритием до давления 333 гПа и выдерживали при 130oС 20 мин. Избыточный тритий удаляли вакуумированием. После охлаждения продукты реакции растворяли в этилацетате (6•1 мл), катализатор отфильтровывали, а фильтраты упаривали несколько раз смесью этилацетата с метанолом (9:1) для удаления лабильного трития. Остаток очищали методом ВЭЖХ. В реакционной смеси содержалось 1,6 мг (32%) меченого филлохинона, а радиохимическая чистота составляла около 18%. После первой хроматографии выделено 1,25 мг (25%) меченого 2-метил-3-фитил-1,4-нафтохинона с радиохимической чистотой 93%. После второй хроматографии выход меченого препарата - 18-22%, молярная радиоактивность - 60-65 Ки/ммоль, радиохимическая чистота - 98-99%.Example 1. In the reaction vial was placed 5 mg of phylloquinone supported on 50 mg of Lindlar catalyst based on 5% Pd / BaS0 4 . Then the ampoule was evacuated to a pressure of 0.1 Pa, filled with gaseous tritium to a pressure of 333 hPa and kept at 130 ° C. for 20 minutes. Excess tritium was removed by evacuation. After cooling, the reaction products were dissolved in ethyl acetate (6 • 1 ml), the catalyst was filtered off, and the filtrates were evaporated several times with a mixture of ethyl acetate and methanol (9: 1) to remove labile tritium. The residue was purified by HPLC. The reaction mixture contained 1.6 mg (32%) of labeled phylloquinone, and the radiochemical purity was about 18%. After the first chromatography, 1.25 mg (25%) of labeled 2-methyl-3-wick-1,4-naphthoquinone with a radiochemical purity of 93% was isolated. After the second chromatography, the yield of the labeled preparation was 18-22%, the molar radioactivity was 60-65 Ci / mmol, and the radiochemical purity was 98-99%.
ВЭЖХ препаративных количеств филлохинона проводили на колонке Kromasil C18, 7 мкм, 4•150 мм, v - 0,8 мл/мин, в системе метанол-хлороформ (90:10), время удерживания - 12,77 мин; аналитические данные получали на колонке Kromasil 100 С18, 6 мкм, 2•80 мм, v - 0,1 мл/мин, в системе метанол-хлороформ (90:10), время удерживания - 11,66 мин.HPLC of preparative amounts of phylloquinone was carried out on a Kromasil C 18 , 7 μm column, 4 • 150 mm, v - 0.8 ml / min, in the methanol-chloroform system (90:10), retention time - 12.77 min; Analytical data were obtained on a Kromasil 100 C 18 , 6 μm, 2 • 80 mm column, v 0.1 ml / min, in a methanol-chloroform system (90:10), retention time 11.66 min.
Для приема и обработки хроматографических данных использовался программно-аппаратный комплекс "МультиХром" (000 "Амперсенд", Россия) на базе IBM PC/AT. Радиоактивность измеряли на сцинтилляционном счетчике с эффективностью регистрации трития 30% в диоксановом сцинтилляторе. For reception and processing of chromatographic data, the MultiKhrom software and hardware complex (000 Ampersend, Russia) based on IBM PC / AT was used. Radioactivity was measured on a scintillation counter with a tritium detection efficiency of 30% in a dioxane scintillator.
Пример 2. Синтез проводили, как описано в примере 1, при температуре 100oС. Выход меченого препарата - 25-30%, молярная радиоактивность - 18-20 Ки/ммоль.Example 2. The synthesis was carried out as described in example 1, at a temperature of 100 o C. The output of the labeled drug is 25-30%, the molar radioactivity is 18-20 Ci / mmol.
Таким образом получен новый высокомеченный тритием филлохинон. Thus, a new highly labeled tritium phyloquinone was obtained.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2001115959/04A RU2190591C1 (en) | 2001-06-15 | 2001-06-15 | 2-methyl-3-phythyl-1,4-naphthoquinone highly labeled with tritium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2001115959/04A RU2190591C1 (en) | 2001-06-15 | 2001-06-15 | 2-methyl-3-phythyl-1,4-naphthoquinone highly labeled with tritium |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2190591C1 true RU2190591C1 (en) | 2002-10-10 |
Family
ID=20250642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2001115959/04A RU2190591C1 (en) | 2001-06-15 | 2001-06-15 | 2-methyl-3-phythyl-1,4-naphthoquinone highly labeled with tritium |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2190591C1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2360896C1 (en) * | 2008-03-19 | 2009-07-10 | Институт молекулярной генетики Российской Академии наук (ИМГ РАН) (Статус Государственного учреждения) | Uniformly marked with tritium tilosin |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2907864B2 (en) * | 1978-03-04 | 1981-04-02 | Wakunaga Yakuhin K.K., Osaka | Process for the preparation of vitamin K ↓ 1 ↓ and vitamin K? 2? |
| US5476955A (en) * | 1993-03-01 | 1995-12-19 | Eisai Chemical Co., Ltd. | Process for the preparation of a quinone derivative |
| RU2151136C1 (en) * | 1998-06-03 | 2000-06-20 | Институт молекулярной генетики РАН | Highly marked substituted carbamates |
-
2001
- 2001-06-15 RU RU2001115959/04A patent/RU2190591C1/en not_active IP Right Cessation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2907864B2 (en) * | 1978-03-04 | 1981-04-02 | Wakunaga Yakuhin K.K., Osaka | Process for the preparation of vitamin K ↓ 1 ↓ and vitamin K? 2? |
| US5476955A (en) * | 1993-03-01 | 1995-12-19 | Eisai Chemical Co., Ltd. | Process for the preparation of a quinone derivative |
| RU2151136C1 (en) * | 1998-06-03 | 2000-06-20 | Институт молекулярной генетики РАН | Highly marked substituted carbamates |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2360896C1 (en) * | 2008-03-19 | 2009-07-10 | Институт молекулярной генетики Российской Академии наук (ИМГ РАН) (Статус Государственного учреждения) | Uniformly marked with tritium tilosin |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fishbein et al. | Preparation and some properties of stable and carbon-14 and tritium-labeled short-chain aliphatic hydroxamic acids | |
| US4789736A (en) | Complexes of technetium-99m with propylene amine oximes | |
| Askari et al. | The reaction sequence in ergothioneine biosynthesis: hercynine as an intermediate | |
| RU2190591C1 (en) | 2-methyl-3-phythyl-1,4-naphthoquinone highly labeled with tritium | |
| EP3594200B1 (en) | Radioactive fluorine-labeled precursor compound, and method for producing radioactive fluorine-labeled compound using same | |
| RU2265025C1 (en) | Highly labeled with tritium [3h]-2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid | |
| JP2002080408A (en) | Method for separating organic compound | |
| RU2144017C1 (en) | Tritium highly marked cyclosporin a | |
| Uccello‐Barretta et al. | 1, 3, 5‐Triazine multiselector systems: New tools for chiral discrimination | |
| RU2151136C1 (en) | Highly marked substituted carbamates | |
| RU2191187C1 (en) | Monofluoroquinolones highly labeled with tritium | |
| RU2136641C1 (en) | Hydrochloric acid (n-nitro)-arginine methyl ester highly marked with tritium | |
| RU2326889C1 (en) | α-HEDERIN UNIFORMLY MARKED WITH TRITIUM | |
| EA009238B1 (en) | High purity butoconazole nitrate with specified particle size and a process for preparation thereof | |
| US4976834A (en) | Asymmetric photochemical reaction process | |
| RU2268256C1 (en) | Tritium high-labeled [3h]-(e)-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-noneneamide | |
| RU2668982C1 (en) | Tritiated 3,7-bis(2,3-dihydro-1-benzofuran-5-ylcarbonyl)-1,5-dimethyl-3,7-diazabicyclo[3.3.1]nonan-9-one | |
| HK1043787A1 (en) | Method crystallising n-(4-trifluoromethylphenyl)-5-methyl-isoxazole-4-carboxamide | |
| RU2229469C1 (en) | Butyrylcholine chloride highly labeled with tritium | |
| EP3753923A1 (en) | Recrystallisation of 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) in methyl tert.-butyl ether (mtbe) without adding an anti-solvent | |
| RU2189971C1 (en) | Highly labeled with tritium | |
| RU2360896C1 (en) | Uniformly marked with tritium tilosin | |
| RU2197457C1 (en) | High-tritium-labeled n-methyl-n-2-propinylbenzylamine | |
| RU2248965C1 (en) | Tritium highly labeled [3h]-(s)-alpha-cyano-3-phenoxybenzyl-(1r)-(2',2'-dibromovinyl)-2,2-dimethyl cyclopropane carboxylate | |
| Shevchenko et al. | Introduction of hydrogen isotopes into maraviroc and mass-spectrometric study of deuterium distribution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20040616 |